Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer’s disease

<i>Coot</i> : model-building tools for molecular graphics

Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571 · see citing works

<i>Phaser</i> crystallographic software

McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612 · see citing works

Refinement of Macromolecular Structures by the Maximum-Likelihood Method

Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,671 · see citing works

Overview of the <i>CCP</i> 4 suite and current developments

Winn, M. D., Ballard, C. C., Cowtan, K. D., Dodson, E. J., Emsley, P., Evans, P. R., Keegan, R. M., Krissinel, E. B., Leslie, A. G. W., McCoy, A., et al. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910045749 · Cited by 12,353 · see citing works

Electrostatics of nanosystems: Application to microtubules and the ribosome

Baker, N., Sept, D., Joseph, S., Holst, M., & McCammon, J. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181342398 · Cited by 7,125 · see citing works

LigPlot+: Multiple Ligand-Protein Interaction Diagrams for Drug Discovery

Laskowski, R., & Swindells, M. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200227u · Cited by 6,159 · see citing works

Towards automated crystallographic structure refinement with <i>phenix.refine</i>

Afonine, P. V., Grosse-Kunstleve, R. W., Echols, N., Headd, J. J., Moriarty, N. W., Mustyakimov, M., Terwilliger, T. C., Urzhumtsev, A., Zwart, P. H., & Adams, P. D. (2012) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444912001308 · Cited by 5,511 · see citing works

New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays

Baell, J. B., & Holloway, G. A. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901137j · Cited by 3,963 · see citing works

MolProbity: all-atom contacts and structure validation for proteins and nucleic acids

Davis, I., Leaver‐Fay, A., Chen, V. B., Block, J. N., Kapral, G. J., Wang, X., Murray, L. W., Arendall, W. B., Snoeyink, J. S., Richardson, J. S., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm216 · Cited by 3,915 · see citing works

Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation

Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · see citing works

PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations

Dolinsky, T. J., Nielsen, J. E., McCammon, J. A., & Baker, N. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh381 · Cited by 3,485 · see citing works

iMOSFLM: a new graphical interface for diffraction-image processing withMOSFLM

Battye, T. G. G., Kontogiannis, L., Johnson, O., Powell, H. R., & Leslie, A. G. W. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910048675 · Cited by 2,869 · see citing works

Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model

Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208 · see citing works

Main-chain Bond Lengths and Bond Angles in Protein Structures

Laskowski, R. A., Moss, D. S., & Thornton, J. M. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1351 · Cited by 1,217 · see citing works

An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans

Bonassi, S., Znaor, A., Ceppi, M., Lando, C., Chang, W. P., Holland, N., Kirsch‐Volders, M., Zeiger, E., Ban, S., Barale, R., et al. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl177 · Cited by 1,024 · see citing works

Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease

Zhang, Z., Song, M., Liu, X., Kang, S. S., Kwon, I.-S., Duong, D. M., Seyfried, N. T., Hu, W. T., Liu, Z., Wang, J.-Z., et al. (2014) · Nature Medicine · doi:10.1038/nm.3700 · Cited by 494 · see citing works

JLigand: a graphical tool for the CCP4 template-restraint library

Lebedev, A. A., Young, P., Isupov, M. N., Moroz, O. V., Vagin, A. A., & Murshudov, G. N. (2012) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s090744491200251x · Cited by 439 · see citing works

Cathepsin-regulated apoptosis

Chwieralski, C. E., Welte, T., & Bühling, F. (2006) · APOPTOSIS · doi:10.1007/s10495-006-3486-y · Cited by 427 · see citing works

Cloning, Isolation, and Characterization of Mammalian Legumain, an Asparaginyl Endopeptidase

Chen, J.-M., Dando, P. M., Rawlings, N. D., Brown, M. A., Young, N. E., Stevens, R., Hewitt, E. W., Watts, C. K. W., & Barrett, A. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.8090 · Cited by 385 · see citing works

PAINS in the Assay: Chemical Mechanisms of Assay Interference and Promiscuous Enzymatic Inhibition Observed during a Sulfhydryl-Scavenging HTS

Dahlin, J. L., Nissink, J. W. M., Strasser, J. M., Francis, S., Higgins, L., Zhou, H., Zhang, Z., & Walters, M. A. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm5019093 · Cited by 362 · see citing works

Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy.

Liu, C., Sun, C., Huang, H., Janda, K. D., & Edgington, T. S. (2003) · PubMed · Cited by 334 · see citing works

Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model

Kimura, R., & Ohno, M. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.10.006 · Cited by 333 · see citing works

Synaptic Loss in the Inferior Temporal Gyrus in Mild Cognitive Impairment and Alzheimer's Disease

Scheff, S. W., PRICE, D. A., Schmitt, F. A., Scheff, M. A., & Mufson, E. J. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101782 · Cited by 301 · see citing works

Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer’s disease

Zhang, Z., Song, M., Liu, X., Kang, S. S., Duong, D. M., Seyfried, N. T., Cao, X., Cheng, L., Sun, Y. E., Yu, S. P., et al. (2015) · Nature Communications · doi:10.1038/ncomms9762 · Cited by 289 · see citing works

7,8-Dihydroxyflavone Prevents Synaptic Loss and Memory Deficits in a Mouse Model of Alzheimer’s Disease

Zhang, Z., Liu, X., Schroeder, J. P., Chan, C.-B., Song, M., Yu, S. P., Weinshenker, D., & Ye, K. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.243 · Cited by 242 · see citing works

ALARM NMR: A Rapid and Robust Experimental Method To Detect Reactive False Positives in Biochemical Screens

Huth, J. R., Mendoza, R. R., Olejniczak, E. T., Johnson, R. W., Cothron, D. A., Liu, Y., Lerner, C. G., Chen, J., & Hajduk, P. J. (2004) · Journal of the American Chemical Society · doi:10.1021/ja0455547 · Cited by 232 · see citing works

Clusterin contributes to caspase-3–independent brain injury following neonatal hypoxia-ischemia

Han, B. H., Demattos, R. B., Dugan, L. L., Kim‐Han, J. S., Brendza, R. P., Fryer, J. D., Kierson, M., Cirrito, J. R., Quick, K. L., Harmony, J. A. K., et al. (2001) · Nature Medicine · doi:10.1038/85487 · Cited by 206 · see citing works

Mechanistic and structural studies on legumain explain its zymogenicity, distinct activation pathways, and regulation

Dall, E., & Brandstetter, H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300686110 · Cited by 194 · see citing works

Setting expectations in molecular optimizations: Strengths and limitations of commonly used composite parameters

Shultz, M. D. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.08.029 · Cited by 175 · see citing works

Activation of Asparaginyl Endopeptidase Leads to Tau Hyperphosphorylation in Alzheimer Disease

Basurto‐Islas, G., Grundke, I., Tung, Y. C., Liu, F., & Iqbal, K. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.446070 · Cited by 141 · see citing works

Neuroprotective Actions of PIKE-L by Inhibition of SET Proteolytic Degradation by Asparagine Endopeptidase

Liu, Z., Jang, S., Liu, X., Cheng, D., Peng, J., Yepes, M., Li, X., Matthews, S., Watts, C. K. W., Asano, M., et al. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.02.017 · Cited by 133 · see citing works

Disulfiram Is a Potent Inhibitor of Proteases of the Caspase Family

Nobel, S., Kimland, M., Nicholson, D. W., Orrenius, S., & Slater, A. F. G. (1997) · Chemical Research in Toxicology · doi:10.1021/tx970131m · Cited by 116 · see citing works

Asparagine Endopeptidase Is Not Essential for Class II MHC Antigen Presentation but Is Required for Processing of Cathepsin L in Mice

Maehr, R., Hang, H. C., Mintern, J. D., Kim, Y., Cuvillier, A., Nishimura, M., Yamada, K., Shirahama‐Noda, K., Hara‐Nishimura, I., & Ploegh, H. L. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.7066 · Cited by 115 · see citing works

Legumain expression as a prognostic factor in breast cancer patients

Gawenda, J., Traub, F., Lück, H. J., Kreipe, H. H., & von Wasielewski, R. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9311-z · Cited by 105 · see citing works

Activation of legumain involves proteolytic and conformational events, resulting in a context- and substrate-dependent activity profile

Dall, E., & Brandstetter, H. (2011) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309111048020 · Cited by 89 · see citing works

Oral DNA vaccines target the tumor vasculature and microenvironment and suppress tumor growth and metastasis

Xiang, R., Luo, Y., Niethammer, A. G., & Reisfeld, R. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00613.x · Cited by 80 · see citing works

Asparagine endopeptidase is required for normal kidney physiology and homeostasis

Miller, G., Matthews, S. P., Reinheckel, T., Fleming, S., & Watts, C. K. W. (2011) · The FASEB Journal · doi:10.1096/fj.10-172312 · Cited by 80 · see citing works

Mice lacking asparaginyl endopeptidase develop disorders resembling hemophagocytic syndrome

Chan, C. B., Abe, M., Hashimoto, N., Hao, C., Williams, I. R., Liu, X., Nakao, S., Yamamoto, A., Zheng, C., Henter, J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809824105 · Cited by 79 · see citing works

Cystatin E/M suppresses legumain activity and invasion of human melanoma

Briggs, J., Haugen, M. H., Johansen, H. T., Riker, A. I., Abrahamson, M., Fodstad, Ø., Mælandsmo, G. M., & Solberg, R. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-17 · Cited by 70 · see citing works

The Legumain Protease‐Activated Auristatin Prodrugs Suppress Tumor Growth and Metastasis without Toxicity

Bajjuri, K. M., Liu, Y., Liu, C., & Sinha, S. C. (2010) · ChemMedChem · doi:10.1002/cmdc.201000478 · Cited by 69 · see citing works

Asparaginyl endopeptidase cleaves TDP‐43 in brain

Herskowitz, J. H., Gozal, Y. M., Duong, D. M., Dammer, E. B., Gearing, M., Ye, K., Lah, J. J., Peng, J., Levey, A. I., & Seyfried, N. T. (2012) · PROTEOMICS · doi:10.1002/pmic.201200006 · Cited by 69 · see citing works

A graphical method for determining inhibition parameters for partial and complete inhibitors

Yoshino, M. (1987) · Biochemical Journal · doi:10.1042/bj2480815 · Cited by 69 · see citing works

Reversible covalent inhibition of papain by a peptide nitrile. Carbon-13 NMR evidence for a thioimidate ester adduct

Moon, J. B., Coleman, R. S., & Hanzlik, R. P. (1986) · Journal of the American Chemical Society · doi:10.1021/ja00266a066 · Cited by 68 · see citing works

Asparaginyl endopeptidase: case history of a class II MHC compartment protease

Watts, C. K. W., Matthews, S. P., Mazzeo, D., Manoury, B., & Moss, C. X. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00312.x · Cited by 66 · see citing works

Screening-Based Translation of Public Research Encounters Painful Problems

Baell, J. B. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00032 · Cited by 64 · see citing works

Small Peptides Blocking Inhibition of Factor Xa and Tissue Factor-Factor VIIa by Tissue Factor Pathway Inhibitor (TFPI)

Dockal, M., Hartmann, R., Fries, M., Thomassen, S., Heinzmann, A. C. A., Ehrlich, H. J., Rosing, J., Osterkamp, F., Polakowski, T., Reineke, U., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.533836 · Cited by 46 · see citing works

A Chloroacetamidine‐Based Inactivator of Protein Arginine Methyltransferase 1: Design, Synthesis, and In Vitro and In Vivo Evaluation

Obianyo, O., Causey, C. P., Osborne, T. C., Jones, J. E., Lee, Y., Stallcup, M. R., & Thompson, P. R. (2010) · ChemBioChem · doi:10.1002/cbic.201000209 · Cited by 46 · see citing works

Novel Cell-Permeable Acyloxymethylketone Inhibitors of Asparaginyl Endopeptidase

Loak, K., Li, D. N., Manoury, B., Billson, J., Morton, F. R., Hewitt, E. W., & Watts, C. K. W. (2003) · Biological Chemistry · doi:10.1515/bc.2003.136 · Cited by 44 · see citing works

Aza-Peptidyl Michael Acceptor and Epoxide Inhibitors—Potent and Selective Inhibitors of Schistosoma mansoni and Ixodes ricinus Legumains (Asparaginyl Endopeptidases)

Ovat, A., Muindi, F. J., Fagan, C., Brouner, M., Hansell, E. J., Dvořák, J., Sojka, D., Kopáček, P., McKerrow, J. H., Caffrey, C. R., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900849h · Cited by 36 · see citing works

Inhibition of Mammalian Legumain by Michael Acceptors and AzaAsn-Halomethylketones

Niestroj, A. J., Feussner, K., Heiser, U. F., Dando, P. M., Barrett, A. J., Gerhartz, B., & Demuth, H. (2002) · Biological Chemistry · doi:10.1515/bc.2002.133 · Cited by 35 · see citing works

Structure of flavonoids influences the degree inhibition of Benzo(a)pyrene – induced DNA damage and micronuclei in HepG2 cells

Kozics, K., Valovičová, Z., & Slameňová, D. (2011) · Neoplasma · doi:10.4149/neo_2011_06_516 · Cited by 27 · see citing works

Development and Implementation of a High Throughput Screen for the Human Sperm-Specific Isoform of Glyceraldehyde 3-Phosphate Dehydrogenase (GAPDHS)

Sexton, J. Z., Danshina, P. V., Lamson, D. R., Hughes, M., House, A. J., Yeh, L.-A., O’Brien, D. A., & Williams, K. P. (2011) · Current Chemical Genomics · doi:10.2174/1875397301105010030 · Cited by 17 · see citing works

Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease

Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00391-7 · Cited by 994 · see citing works

The complexity of tau in Alzheimer’s disease

Naseri, N. N., Wang, H., Guo, J. D., Sharma, M., & Luo, W. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.04.022 · Cited by 374 · see citing works

Proteolytic ectodomain shedding of membrane proteins in mammals—hardware, concepts, and recent developments

Lichtenthaler, S. F., Lemberg, M. K., & Fluhrer, R. (2018) · The EMBO Journal · doi:10.15252/embj.201899456 · Cited by 298 · see citing works

Dendritic Tau in Alzheimer’s Disease

Ittner, A., & Ittner, L. M. (2018) · Neuron · doi:10.1016/j.neuron.2018.06.003 · Cited by 278 · see citing works

Updates in Alzheimer's disease: from basic research to diagnosis and therapies

Liu, E., Zhang, Y., & Wang, J. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00432-x · Cited by 220 · see citing works

Tau Proteolysis in the Pathogenesis of Tauopathies: Neurotoxic Fragments and Novel Biomarkers

Quinn, J. P., Corbett, N. J., Kellett, K. A. B., & Hooper, N. M. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-170959 · Cited by 170 · see citing works

The prodrug of 7,8-dihydroxyflavone development and therapeutic efficacy for treating Alzheimer’s disease

Chen, C., Wang, Z., Zhang, Z., Liu, X., Kang, S. S., Zhang, Y., & Ye, K. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718683115 · Cited by 169 · see citing works

TrkB/BDNF signaling pathway and its small molecular agonists in CNS injury

Wang, Y., Liang, J., Xu, B., Yang, J., Wu, Z., & Cheng, L. (2024) · Life Sciences · doi:10.1016/j.lfs.2023.122282 · Cited by 152 · see citing works

Norepinephrine metabolite DOPEGAL activates AEP and pathological Tau aggregation in locus coeruleus

Kang, S. S., Liu, X., Ahn, E. H., Xiang, J., Manfredsson, F. P., Yang, X., Luo, H. R., Liles, L. C., Weinshenker, D., & Ye, K. (2019) · Journal of Clinical Investigation · doi:10.1172/jci130513 · Cited by 117 · see citing works

Cerebrospinal fluid tau fragment correlates with tau PET: a candidate biomarker for tangle pathology

Blennow, K., Chen, C., Cicognola, C., Wildsmith, K. R., Manser, P. T., Bohorquez, S. M. S., Zhang, Z., Xie, B., Peng, J., Hansson, O., et al. (2020) · Brain · doi:10.1093/brain/awz346 · Cited by 105 · see citing works

Initiation of Parkinson’s disease from gut to brain by δ-secretase

Ahn, E. H., Kang, S. S., Liu, X., Chen, G., Zhang, Z., Chandrasekharan, B. P., Alam, A. M., Neish, A. S., Cao, X., & Ye, K. (2019) · Cell Research · doi:10.1038/s41422-019-0241-9 · Cited by 103 · see citing works

α‐Synuclein stimulation of monoamine oxidase‐B and legumain protease mediates the pathology of Parkinson's disease

Kang, S. S., Ahn, E. H., Zhang, Z., Liu, X., Manfredsson, F. P., Sandoval, I. M., Dhakal, S., Iuvone, P. M., Cao, X., & Ye, K. (2018) · The EMBO Journal · doi:10.15252/embj.201798878 · Cited by 100 · see citing works

Occurrence of Morpholine in Central Nervous System Drug Discovery

Lenci, E., Calugi, L., & Trabocchi, A. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00729 · Cited by 97 · see citing works

Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies

Zhang, X., Wang, J., Zhang, Z., & Ye, K. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00429-6 · Cited by 106 · see citing works

Trafficking and proteolytic processing of amyloid precursor protein and secretases in Alzheimer's disease development: An up-to-date review

Yuksel, M., & Tacal, Ö. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172415 · Cited by 94 · see citing works

A monomeric polysaccharide from Polygonatum sibiricum improves cognitive functions in a model of Alzheimer's disease by reshaping the gut microbiota

Luo, S., Zhang, X., Huang, S. Q., Feng, X., Zhang, X., & Xiang, D.-X. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.05.185 · Cited by 92 · see citing works

Emerging Alternative Proteinases in APP Metabolism and Alzheimer’s Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP

García‐González, L., Piłat, D., Baranger, K., & Rivera, S. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00244 · Cited by 81 · see citing works

Traumatic brain injury triggers APP and Tau cleavage by delta-secretase, mediating Alzheimer’s disease pathology

Wu, Z., Wang, Z.-H., Liu, X., Zhang, Z., Gu, X., Yu, S. P., Keene, C. D., Cheng, L., & Ye, K. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101730 · Cited by 81 · see citing works

High-Throughput Screening for the Discovery of Enzyme Inhibitors

Lloyd, M. D. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00523 · Cited by 81 · see citing works

δ-secretase in neurodegenerative diseases: mechanisms, regulators and therapeutic opportunities

Zhang, Z., Tian, Y., & Ye, K. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-019-0179-3 · Cited by 81 · see citing works

High-fat diet-induced diabetes couples to Alzheimer’s disease through inflammation-activated C/EBPβ/AEP pathway

Liu, P., Wang, Z.-H., Kang, S. S., Liu, X., Xia, Y., Chan, C.-B., & Ye, K. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01600-z · Cited by 77 · see citing works

Delta-secretase-cleaved Tau antagonizes TrkB neurotrophic signalings, mediating Alzheimer’s disease pathologies

Xiang, J., Wang, Z.-H., Ahn, E. H., Liu, X., Yu, S.-P., Manfredsson, F. P., Sandoval, I. M., Ju, G., Wu, S., & Ye, K. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901348116 · Cited by 67 · see citing works

Amyloid Cascade Hypothesis for the Treatment of Alzheimer’s Disease: Progress and Challenges

Wu, T., Ding, L., Cheng, Y., Jiang, S., Riaz, M. W., Fu, N., Mou, C., Ye, M., & Zheng, Y. (2022) · Aging and Disease · doi:10.14336/ad.2022.0412 · Cited by 75 · see citing works

The amyloid precursor protein: a converging point in Alzheimer’s disease

Delport, A., & Hewer, R. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02863-x · Cited by 62 · see citing works

Targeting tau in Alzheimer's disease: from mechanisms to clinical therapy

Ye, J., Wan, H., Chen, S., & Liu, G. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385847 · Cited by 69 · see citing works

Delta-Secretase Phosphorylation by SRPK2 Enhances Its Enzymatic Activity, Provoking Pathogenesis in Alzheimer’s Disease

Wang, Z.-H., Liu, P., Liu, X., Manfredsson, F. P., Sandoval, I. M., Yu, S. P., Wang, J., & Ye, K. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.07.018 · Cited by 64 · see citing works

Hypoxia-driven protease legumain promotes immunosuppression in glioblastoma

Pang, L., Guo, S., Khan, F., Dunterman, M., Ali, H. A., Liu, Y., Huang, Y.-Y., & Chen, P. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101238 · Cited by 58 · see citing works

CK2 Phosphorylating I2PP2A/SET Mediates Tau Pathology and Cognitive Impairment

Zhang, Q., Xia, Y., Wang, Y., Shentu, Y., Zeng, K., Mahaman, Y. A. R., Huang, F., Wu, M., Ke, D., Wang, Q., et al. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00146 · Cited by 51 · see citing works

BDNF inhibits neurodegenerative disease–associated asparaginyl endopeptidase activity via phosphorylation by AKT

Wang, Z.-H., Wu, W., Kang, S. S., Liu, X., Wu, Z., Peng, J., Yu, S. P., Manfredsson, F. P., Sandoval, I. M., Liu, X., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.99007 · Cited by 52 · see citing works

A Review of the Recent Advances in Alzheimer’s Disease Research and the Utilization of Network Biology Approaches for Prioritizing Diagnostics and Therapeutics

Hajjo, R., Sabbah, D. A., Abusara, O. H., & Bawab, A. Q. A. (2022) · Diagnostics · doi:10.3390/diagnostics12122975 · Cited by 55 · see citing works

Targeting both BDNF/TrkB pathway and delta-secretase for treating Alzheimer's disease

Liao, J., Chen, C., Ahn, E. H., Liu, X., Li, H., Edgington‐Mitchell, L. E., Lu, Z., Ming, S., & Ye, K. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108737 · Cited by 50 · see citing works

Brothers in Arms: ProBDNF/BDNF and sAPPα/Aβ-Signaling and Their Common Interplay with ADAM10, TrkB, p75NTR, Sortilin, and sorLA in the Progression of Alzheimer’s Disease

Eggert, S., Kins, S., Endres, K., & Brigadski, T. (2022) · Biological Chemistry · doi:10.1515/hsz-2021-0330 · Cited by 46 · see citing works

The Mammalian Cysteine Protease Legumain in Health and Disease

Solberg, R., Lunde, N. N., Forbord, K. M., Okla, M., Kassem, M. S., & Jafari, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415983 · Cited by 52 · see citing works

Neuronal C/EBPβ/AEP pathway shortens life span via selective GABAnergic neuronal degeneration by FOXO repression

Xia, Y., Qadota, H., Wang, Z.-H., Liu, P., Liu, X., Ye, K. X., Matheny, C. J., Berglund, K., Yu, S. P., Drake, D., et al. (2022) · Science Advances · doi:10.1126/sciadv.abj8658 · Cited by 46 · see citing works

ApoE4 inhibition of VMAT2 in the locus coeruleus exacerbates Tau pathology in Alzheimer’s disease

Kang, S. S., Ahn, E. H., Liu, X., Bryson, M., Miller, G. W., Weinshenker, D., & Ye, K. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02315-1 · Cited by 48 · see citing works

Nature of Tau-Associated Neurodegeneration and the Molecular Mechanisms

Yang, Y., & Wang, J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170788 · Cited by 46 · see citing works

Blockade of Asparagine Endopeptidase Inhibits Cancer Metastasis

Qi, Q., Obianyo, O., Du, Y., Fu, H., Li, S., & Ye, K. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00228 · Cited by 45 · see citing works

Delta-secretase cleavage of Tau mediates its pathology and propagation in Alzheimer’s disease

Kang, S. S., Ahn, E. H., & Ye, K. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00494-7 · Cited by 45 · see citing works

Kinetics of human mutant tau prion formation in the brains of 2 transgenic mouse lines

Woerman, A. L., Patel, S., Kazmi, S. A., Oehler, A., Freyman, Y., Espiritu, L., Cotter, R., Castaneda, J. A., Olson, S. H., & Prusiner, S. B. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.2822 · Cited by 44 · see citing works

In Silico Molecular Docking Analysis of Potential Anti-Alzheimer's Compounds Present in Chloroform Extract of Carissa carandas Leaf Using Gas Chromatography MS/MS

Kareti, S. R., & Subash, P. (2020) · Current Therapeutic Research · doi:10.1016/j.curtheres.2020.100615 · Cited by 43 · see citing works

Treating Parkinson's Disease via Activation of BDNF/TrkB Signaling Pathways and Inhibition of Delta-Secretase

Kang, S. S., Wu, Z., Liu, X., Edgington‐Mitchell, L. E., & Ye, K. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01248-1 · Cited by 43 · see citing works

TrkB receptor cleavage by delta-secretase abolishes its phosphorylation of APP, aggravating Alzheimer’s disease pathologies

Xia, Y., Wang, Z.-H., Liu, P., Edgington‐Mitchell, L. E., Liu, X., Wang, X., & Ye, K. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00863-8 · Cited by 42 · see citing works

A delta-secretase-truncated APP fragment activates CEBPB, mediating Alzheimer’s disease pathologies

Yao, Y., Kang, S. S., Xia, Y., Wang, Z.-H., Liu, X., Müller, T., Sun, Y. E., & Ye, K. (2021) · Brain · doi:10.1093/brain/awab062 · Cited by 42 · see citing works

Optimized TrkB Agonist Ameliorates Alzheimer’s Disease Pathologies and Improves Cognitive Functions via Inhibiting Delta-Secretase

Chen, C., Ahn, E. H., Liu, X., Wang, Z.-H., Luo, S., Liao, J., & Ye, K. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00181 · Cited by 42 · see citing works

Exposure to the environmentally toxic pesticide maneb induces Parkinson's disease-like neurotoxicity in mice: A combined proteomic and metabolomic analysis

Liu, C., Liu, Z., Fang, Y., Du, Z., Yan, Z., Yuan, X., Dai, L., Yu, T., Xiong, M., Tian, Y., et al. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.136344 · Cited by 37 · see citing works

Delta-secretase (AEP) mediates tau-splicing imbalance and accelerates cognitive decline in tauopathies

Wang, Z.-H., Liu, P., Liu, X., Yu, S. P., Wang, J., & Ye, K. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20180539 · Cited by 36 · see citing works

Asparagine endopeptidase-targeted Ultrasound-responsive Nanobubbles Alleviate Tau Cleavage and Amyloid-β Deposition in an Alzheimer's Disease Model

Mi, X., Du, H., Guo, X., Wu, Y., Shen, L., Luo, Y., Wang, D., Su, Q., Xiang, R., Yue, S., et al. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.01.023 · Cited by 36 · see citing works

C/EBPβ/AEP Signaling Drives Alzheimer’s Disease Pathogenesis

Xiong, J., Zhang, Z., & Ye, K. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01025-w · Cited by 37 · see citing works

Nutraceutical and therapeutic potential of Phycocyanobilin for treating Alzheimer’s disease

Piniella‐Matamoros, B., Marín‐Prida, J., & Pentón‐Rol, G. (2021) · Journal of Biosciences · doi:10.1007/s12038-021-00161-7 · Cited by 34 · see citing works

Islet amyloid polypeptide triggers α-synuclein pathology in Parkinson’s disease

Meng, L., Li, Y., Liu, C., Zhang, G., Chen, J., Xiong, M., Pan, L., Zhang, X., Chen, G., Xiong, J., et al. (2023) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2023.102462 · Cited by 33 · see citing works

REMOVED: Nanowired delivery of cerebrolysin with neprilysin and p-Tau antibodies induces superior neuroprotection in Alzheimer's disease

Sharma, H. S., Muresanu, D. F., Nozari, A., Lafuente, J. V., Tian, Z. R., Ozkızılcık, A., Manzhulo, I., Mössler, H., & Sharma, A. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.03.009 · Cited by 33 · see citing works

Spatiotemporal activation of the C/EBPβ/δ-secretase axis regulates the pathogenesis of Alzheimer’s disease

Wang, H., Liu, X., Chen, S., & Ye, K. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815915115 · Cited by 32 · see citing works

C/EBPβ/AEP Signaling Regulates the Oxidative Stress in Malignant Cancers, Stimulating the Metastasis

Lei, K., Kang, S. S., Ahn, E. H., Chen, C., Liao, J., Liu, X., Li, H., Edgington‐Mitchell, L. E., Jin, L., & Ye, K. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-21-0019 · Cited by 32 · see citing works

Legumain Promotes Atherosclerotic Vascular Remodeling

Ozawa, N., Sato, Y., Mori, Y., Masuda, H., Yamane, M., Yamamoto, Y., Shirai, R., Watanabe, R., Sato, K., Mori, Y., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092195 · Cited by 32 · see citing works

UNC5C Receptor Proteolytic Cleavage by Active AEP Promotes Dopaminergic Neuronal Degeneration in Parkinson's Disease

Chen, G., Ahn, E. H., Kang, S. S., Xia, Y., Liu, X., Zhang, Z., & Ye, K. (2022) · Advanced Science · doi:10.1002/advs.202103396 · Cited by 28 · see citing works

The Asparaginyl Endopeptidase Legumain: An Emerging Therapeutic Target and Potential Biomarker for Alzheimer’s Disease

Song, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810223 · Cited by 30 · see citing works

Structural and functional analysis of cystatin E reveals enzymologically relevant dimer and amyloid fibril states

Dall, E., Hollerweger, J. C., Dahms, S. O., Cui, H., Häußermann, K., & Brandstetter, H. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002154 · Cited by 30 · see citing works

Exercise Rehabilitation and/or Astragaloside Attenuate Amyloid-beta Pathology by Reversing BDNF/TrkB Signaling Deficits and Mitochondrial Dysfunction

Wang, Y., Chio, C., Kuo, S., Yeh, C., Ma, J., Liu, W., Lin, M.-T., Lin, K., & Chang, C. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02728-3 · Cited by 26 · see citing works

Knockout of microglial Hv1 proton channel reduces neurotoxic A1 astrocytes and neuronal damage via the ROS / STAT3 pathway after spinal cord injury

Li, Y., Xie, Y., Liu, R., Wang, Z., Chen, P., Wang, M., Yu, Z., Wang, W., & Luo, X. (2023) · Glia · doi:10.1002/glia.24433 · Cited by 28 · see citing works

C/EBPβ/AEP signaling couples atherosclerosis to the pathogenesis of Alzheimer’s disease

Liao, J., Chen, G., Liu, X., Wei, Z. Z., Yu, S. P., Chen, Q., & Ye, K. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01556-0 · Cited by 25 · see citing works

Lysophosphatidic acid induces neuronal cell death via activation of asparagine endopeptidase in cerebral ischemia-reperfusion injury

Wang, C., Zhang, J., Tang, J., Li, Y.-Y., Gu, Y., Yu, Y., Xiong, J., Zhao, X., Zhang, Z., Li, T., et al. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.04.010 · Cited by 24 · see citing works

Legumain Knockout Protects Against Aβ1–42-Induced AD-like Cognitive Deficits and Synaptic Plasticity Dysfunction Via Inhibiting Neuroinflammation Without Cleaving APP

Chen, R., Zhang, Q., Yan, Y., Zhang, Y., & Zhang, T. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02219-3 · Cited by 24 · see citing works

The yeast prion protein Sup35 initiates α-synuclein pathology in mouse models of Parkinson’s disease

Meng, L., Liu, C., Li, Y., Chen, G., Xiong, M., Yu, T., Pan, L., Zhang, X., Zhou, L., Guo, T., et al. (2023) · Science Advances · doi:10.1126/sciadv.adj1092 · Cited by 24 · see citing works

Pharmacological inhibition of asparaginyl endopeptidase by δ-secretase inhibitor 11 mitigates Alzheimer’s disease-related pathologies in a senescence-accelerated mouse model

Wang, J., Hu, H., Liu, Z., Liu, J., Wang, S., Cheng, Q., Chen, H., & Song, M. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00235-4 · Cited by 22 · see citing works

The Peptide Ligase Activity of Human Legumain Depends on Fold Stabilization and Balanced Substrate Affinities

Dall, E., Stanojlović, V., Demir, F., Briza, P., Dahms, S. O., Huesgen, P. F., Cabrele, C., & Brandstetter, H. (2021) · ACS Catalysis · doi:10.1021/acscatal.1c02057 · Cited by 22 · see citing works

Network-based identification of miRNAs and transcription factors and in silico drug screening targeting δ-secretase involved in Alzheimer's disease

Iqbal, S., Malik, M. Z., & Pal, D. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e08502 · Cited by 22 · see citing works

The pyrethroids metabolite 3-phenoxybenzoic acid induces dopaminergic degeneration

Wan, F. J., Yu, T., Hu, J., Yin, S., Li, Y., Kou, L., Chi, X., Wu, J., Sun, Y., Zhou, Q., et al. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.156027 · Cited by 22 · see citing works

Inhibition of asparagine endopeptidase (AEP) effectively treats sporadic Alzheimer’s disease in mice

Qian, Z., Li, B.-W., Meng, X., Liao, J., Wang, G., Li, Y., Luo, Q., & Ye, K.-Q. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01774-2 · Cited by 19 · see citing works

N-Terminomics/TAILS Profiling of Macrophages after Chemical Inhibition of Legumain

Anderson, B. M., de Almeida, L. G. N., Sekhon, H., Young, D. W., Dufour, A., & Edgington‐Mitchell, L. E. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00821 · Cited by 22 · see citing works

Delta- and beta- secretases crosstalk amplifies the amyloidogenic pathway in Alzheimer’s disease

Xia, Y., Wang, Z.-H., Zhang, Z., Liu, X., Yu, S. P., Wang, J., Wang, X., & Ye, K. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2021.102113 · Cited by 21 · see citing works

Discovery of Orally Available and Brain Penetrant AEP Inhibitors

Krummenacher, D., He, W., Kuhn, B., Schnider, C., Beurier, A., Brom, V., Sivasothy, T., Marty, C., Tosstorff, A., Hewings, D. S., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01804 · Cited by 21 · see citing works

Asparagine endopeptidase inhibitor protects against fenpropathrin-induced neurodegeneration via suppressing α-synuclein aggregation and neuroinflammation

Yu, T., Wan, F. J., Liu, C., Zhang, X., Liu, Z., Zhang, J., Xiong, J., Wang, T., & Zhang, Z. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173586 · Cited by 21 · see citing works

Target Enzymes Considered for the Treatment of Alzheimer’s Disease and Parkinson’s Disease

Kim, N., & Lee, H. J. (2020) · BioMed Research International · doi:10.1155/2020/2010728 · Cited by 21 · see citing works

Targeting legumain-mediated cell-cell interaction sensitizes glioblastoma to immunotherapy in preclinical models

Pang, L., Guo, S., Huang, Y.-Y., Khan, F., Liu, Y., Fei, Z., Lathia, J. D., & Chen, P. (2025) · Journal of Clinical Investigation · doi:10.1172/jci186034 · Cited by 20 · see citing works

Asparaginyl endopeptidase protects against podocyte injury in diabetic nephropathy through cleaving cofilin-1

Lei, C., Li, M., Qiu, Y., Xie, Y., Hao, Z., Yin, X., Zhang, Z., Su, H., Yang, L., Lin, J., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04621-2 · Cited by 21 · see citing works

Cofilin promotes tau pathology in Alzheimer’s disease

Yan, M., Tang, L., Dai, L., Lei, C., Xiong, M., Zhang, X., He, M., Tian, Y., Xiong, J., Ke, W., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112138 · Cited by 20 · see citing works

Spinal cord injury-activated C/EBPβ-AEP axis mediates cognitive impairment through APP C586/Tau N368 fragments spreading

Wu, Z., Zhu, R., Yu, Y., Wang, J., Hu, X., Xu, W., Ren, Y., Li, C., Zeng, Z., Ma, B., et al. (2023) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2023.102467 · Cited by 20 · see citing works

Microglia CREB-Phosphorylation Mediates Amyloid-β-Induced Neuronal Toxicity

Gao, Y., Liu, E.-J., Wang, W.-J., Wang, Y., Li, X., Wang, X., Li, S., Zhang, S., Li, M., Zhou, Q., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180286 · Cited by 18 · see citing works

Ion Mobility–Based Enrichment-Free N-Terminomics Analysis Reveals Novel Legumain Substrates in Murine Spleen

Ziegler, A. R., Dufour, A., Scott, N. E., & Edgington‐Mitchell, L. E. (2024) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2024.100714 · Cited by 18 · see citing works

Development of a smart activity-based probe to detect subcellular activity of asparaginyl endopeptidase in living cells

Hong, J., Choi, N.-E., La, Y.-K., Nam, H. Y., Seo, J., & Lee, J. (2017) · Organic & Biomolecular Chemistry · doi:10.1039/c7ob01467h · Cited by 17 · see citing works

Heat-related illness and dementia: a study integrating epidemiological and experimental evidence

Kuo, W.-Y., Huang, C., Chen, C., Ho, C., Tang, L.-Y., Lin, H., Su, S., Wang, J., Hsu, C., Chang, C., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01515-7 · Cited by 16 · see citing works

Microglia Process α‐Synuclein Fibrils and Enhance their Pathogenicity in a TREM2‐Dependent Manner

Xiong, M., Xia, D., Yu, H., Meng, L., Zhang, X., Chen, J., Tian, Y., Yuan, X., Niu, X., Nie, S., et al. (2024) · Advanced Science · doi:10.1002/advs.202413451 · Cited by 17 · see citing works

In silico exploration of anti-Alzheimer's compounds present in methanolic extract of Neolamarckia cadamba bark using GC–MS/MS

Kareti, S. R., & Subash, P. (2020) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2020.05.035 · Cited by 16 · see citing works

Pharmacological Inhibition of the Asparaginyl Endopeptidase (AEP) in an Alzheimer’s Disease Model Improves the Survival and Efficacy of Transplanted Neural Stem Cells

Cheng, Q., Ma, X., Liu, J., Feng, X., Liu, Y., Wang, Y., Ni, W., & Song, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097739 · Cited by 14 · see citing works

Biological evaluation and interaction mechanism of beta-site APP cleaving enzyme 1 inhibitory pentapeptide from egg albumin

Yu, Z., Wu, S., Zhao, W., Ding, L., Shiuan, D., Zheng, F., Li, J., & Liu, J. (2020) · Food Science and Human Wellness · doi:10.1016/j.fshw.2020.01.004 · Cited by 14 · see citing works

Spodium Bonds Involving Methylmercury and Ethylmercury in Proteins: Insights from X-ray Analysis and Computations

Burguera, S., Sahu, A. K., Frontera, A., Biswal, H. S., & Bauzá, A. (2023) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.3c02716 · Cited by 13 · see citing works

A novel transgenic mouse line with hippocampus-dominant and inducible expression of truncated human tau

Gao, Y., Wang, Y., Lei, H., Xu, Z., Li, S., Yu, H., Xie, J., Zhang, Z., Liu, G., Zhang, Y., et al. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00379-5 · Cited by 13 · see citing works

Cholestanol accelerates α-synuclein aggregation and spreading by activating asparagine endopeptidase

Yu, T., Nie, S., Bu, L., Liu, M., He, J., Niu, X., Feng, H., Guo, J., Tang, B., Zhang, Z., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.165841 · Cited by 12 · see citing works

Blockage of AEP attenuates TBI-induced tau hyperphosphorylation and cognitive impairments in rats

Liu, Y., Guo, C., Ding, Y., Long, X., Li, W., Ke, D., Wang, Q., Liu, R., Wang, J., Zhang, H., et al. (2020) · Aging · doi:10.18632/aging.103841 · Cited by 12 · see citing works

Transgenic Mice Expressing Human α-Synuclein 1-103 Fragment as a Novel Model of Parkinson’s Disease

Tian, Y., He, M., Pan, L., Yuan, X., Xiong, M., Meng, L., Yao, Z., Yu, Z., Ye, K., & Zhang, Z. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.760781 · Cited by 12 · see citing works

Legumain-induced intracerebrally crosslinked vesicles for suppressing efflux transport of Alzheimer's disease multi-drug nanosystem

Jiang, F., Ren, J., Gao, Y., Wang, J., Zhao, Y., & Dai, F. (2020) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.11.024 · Cited by 11 · see citing works

Imaging asparaginyl endopeptidase (AEP) in the live brain as a biomarker for Alzheimer’s disease

Wang, S., Liu, Z., Liu, J., Cheng, Q., Wang, Y., Liu, Y., Ni, W.-W., Chen, H., & Song, M. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00988-0 · Cited by 11 · see citing works

In silico molecular docking analysis for potential anti-Alzheimer's compounds from the methanolic leaf extract of Erythroxylum monogynum using Gas chromatography–mass spectrometry

Subash, P., & Rao, K. S. (2021) · Journal of Saudi Chemical Society · doi:10.1016/j.jscs.2021.101285 · Cited by 11 · see citing works

Development of asparagine endopeptidase inhibitors for treating neurodegenerative diseases

Meng, X., Li, B., Wang, M., Zheng, W., & Ye, K. (2025) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2025.01.009 · Cited by 10 · see citing works

Sox6 and ALDH1A1 Truncation by Asparagine Endopeptidase Defines Selective Neuronal Vulnerability in Parkinson's Disease

Nie, S., Li, B., Wang, M., Chen, Z., Ren, J., Li, Z., Xu, X., Qian, Z., Xie, Z., Han, J., et al. (2024) · Advanced Science · doi:10.1002/advs.202409477 · Cited by 9 · see citing works

Distinct factors drive the progression of tau pathology in Alzheimer’s disease

Luo, Y., Yu, H., & Ye, K. (2025) · Fundamental Research · doi:10.1016/j.fmre.2025.04.001 · Cited by 8 · see citing works

STAT3 ameliorates truncated tau-induced cognitive deficits

Zhang, B., Wan, H., Maierwufu, M., Liu, Q., Li, T., He, Y., Wang, X., Liu, G., Hong, X., & Feng, Q. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.382253 · Cited by 8 · see citing works

A tau fragment links depressive-like behaviors and cognitive declines in Alzheimer’s disease mouse models through attenuating mitochondrial function

Wang, Y., Wang, J., Chen, H., Li, X., Xu, R., Gao, F., Yu, H., Li, F., Qin, D., Wang, J., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1293164 · Cited by 8 · see citing works

Functional recombinant human Legumain protein expression in Pichia pastoris to enable screening for Legumain small molecule inhibitors

Zhao, T., Li, Z., Guo, Z., Wang, A., Liu, Z., Zhao, Q. S., Li, Y., McKenzie, E. A., & Diao, A. (2018) · Protein Expression and Purification · doi:10.1016/j.pep.2018.05.003 · Cited by 8 · see citing works

Increased cross-linking micelle retention in the brain of Alzheimer's disease mice by elevated asparagine endopeptidase protease responsive aggregation

Ren, J., Jiang, F., Wang, M., Hu, H., Zhang, B., Chen, L., & Dai, F. (2020) · Biomaterials Science · doi:10.1039/d0bm01439g · Cited by 8 · see citing works

Pharmacological inhibition of asparaginyl endopeptidase by δ-secretase inhibitor 11 mitigates Alzheimer’s disease-related pathologies in a senescence-accelerated mouse model

Wang, J., Hu, H., Liu, Z., Liu, J., Wang, S., Cheng, Q., Chen, H., & Song, M. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00235-4 · Cited by 22 · see citing works

Targeting both BDNF/TrkB pathway and delta-secretase for treating Alzheimer's disease

Liao, J., Chen, C., Ahn, E. H., Liu, X., Li, H., Edgington‐Mitchell, L. E., Lu, Z., Ming, S., & Ye, K. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108737 · Cited by 50 · see citing works

Additional file 1 of Pharmacological inhibition of asparaginyl endopeptidase by δ-secretase inhibitor 11 mitigates Alzheimer’s disease-related pathologies in a senescence-accelerated mouse model

Wang, J., Hu, H.-J., Liu, Z.-K., Liu, J.-J., Wang, S.-S., Cheng, Q., Hongzhuan, C. H. E. N., & Song, M. (2021) · Figshare · doi:10.6084/m9.figshare.14355010

Delta-secretase triggers Alzheimer’s disease pathologies in wild-type hAPP/hMAPT double transgenic mice

Wu, Z., Liu, X., Cheng, L., & Ye, K. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03270-7 · Cited by 18 · see citing works

P1‐150: DELTA‐ AND BETA‐SECRETASES CROSSTALK AMPLIFIES THE AMYLOIDOGENIC PATHWAY IN ALZHEIMER'S DISEASE

Xia, Y., Wang, Z., Wang, J., Wang, X., & Ye, K. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.06.705